Inmed to participate in fireside chat with water tower research on july 25, 2023 at 2pm et

Vancouver, british columbia--(newsfile corp. - july 21, 2023) - inmed pharmaceuticals inc. (nasdaq: inm) ("inmed" or the "company"), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today announce jerry griffin, vp of sales and marketing for inmed's subsidiary baymedica llc ("baymedica"), a leading supplier of bioidentical rare cannabinoids to the health and wellness ("h&w") market, will be participating in the water tower research fireside chat series on july 25, 2023, at 2:00 pm et. this event is open access for all investors.
INM Ratings Summary
INM Quant Ranking